BioNTech Has Had a Rough Year. Why It's a Stock Worth Owning.
BioNTech, like all Covid-19 vaccine makers, has gotten crunched in 2023. But it has so much cash that it would have appealed to Warren Buffett’s mentor,...
Stay updated with breaking news from Immunizations. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
BioNTech, like all Covid-19 vaccine makers, has gotten crunched in 2023. But it has so much cash that it would have appealed to Warren Buffett’s mentor,...
Voters are not enthusiastic about a Biden-Trump rematch, and alternatives like Kennedy or the No Labels third-party movement, which would typically be longshots, see an opening
The rapidly growing JN.1 coronavirus subvariant is now responsible for approximately one-third of new COVID-19 infections in the Northeast U.S., compared to about 20% of new infections across the country
FILE - Opponents of a bill to repeal Connecticut's religious exemption for required school vaccinations march down Capitol Avenue before the State Senate voted on legislation on April 27, 2021,
Vaccinations were stopped after it became clear they would not be effective. "We cannot and will not lose hope that the world will have an effective HIV vaccine," the International AIDS director said.